Glycogen synthase kinase-3 beta (GSK3B) is a glycogen metabolism enzyme that upregulates NF-κB activity, a key driver of proliferation and survival in ovarian cancer cells, and inhibition of GSK3B caused tumor shrinkage in mice [5–7]. Here, GSK3B is linked to ovarian carcinoma.